These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 30367545)
1. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1. Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545 [TBL] [Abstract][Full Text] [Related]
2. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms. Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334 [TBL] [Abstract][Full Text] [Related]
3. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
4. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041 [TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway. Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383 [TBL] [Abstract][Full Text] [Related]
7. OPN induces FoxM1 expression and localization through ERK 1/2, AKT, and p38 signaling pathway in HEC-1A cells. Xie Y; Li Y; Kong Y Int J Mol Sci; 2014 Dec; 15(12):23345-58. PubMed ID: 25522167 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis. Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044 [TBL] [Abstract][Full Text] [Related]
9. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway. Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122 [TBL] [Abstract][Full Text] [Related]
11. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247 [TBL] [Abstract][Full Text] [Related]
12. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer. Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531 [TBL] [Abstract][Full Text] [Related]
13. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613 [TBL] [Abstract][Full Text] [Related]
15. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop. Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662 [TBL] [Abstract][Full Text] [Related]
16. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer. Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563 [TBL] [Abstract][Full Text] [Related]
17. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Bao B; Wang Z; Ali S; Kong D; Banerjee S; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH J Cell Biochem; 2011 Sep; 112(9):2296-306. PubMed ID: 21503965 [TBL] [Abstract][Full Text] [Related]
18. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation. Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703 [TBL] [Abstract][Full Text] [Related]
19. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547 [TBL] [Abstract][Full Text] [Related]
20. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]